Adela Partners with Dendi to Commercialize Innovative Cancer Detection Platform
Adela Partners with Dendi to Commercialize Innovative Cancer Detection Platform Dendi’s laboratory information system will support Adela in effectively delivering its MRD clinical diagnostics test to patients and providers. Durham, NC, (March 17, 2025) – Adela, an innovator in blood testing for early cancer detection, has chosen Dendi to extend its genome-wide methylome enrichment technology […]